As of today (2023-09-26), Merck's share price is $105.84.
Merck's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $4.26. Hence, Merck's Price-to-Free-Cash-Flow Ratio for today is 24.86.
The historical rank and industry rank for Merck's Price-to-Free-Cash-Flow or its related term are showing as below:
MRK'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 11.79 Med: 21.1 Max: 39.38
Current: 24.86
During the past 13 years, Merck's highest Price-to-Free-Cash-Flow Ratio was 39.38. The lowest was 11.79. And the median was 21.10.
MRK's Price-to-Free-Cash-Flow is ranked worse than 52.23% of 494
companies
in the Drug Manufacturers industry
Industry Median: 23.36
vs MRK: 24.86
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Merck was -25.00% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 14.00% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 19.80% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was 4.60% per year.
During the past 13 years, Merck's highest 3-Year average Free Cash Flow per Share Growth Rate was 45.60% per year. The lowest was -31.50% per year. And the median was 7.50% per year.
Merck Price-to-Free-Cash-Flow Historical Data
The historical data trend for Merck's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Merck Annual Data
Trend
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Price-to-Free-Cash-Flow
23.50
22.22
34.03
20.13
19.18
Merck Quarterly Data
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Price-to-Free-Cash-Flow
16.07
14.34
19.18
24.03
27.10
Competitive Comparison
For the Drug Manufacturers - General subindustry, Merck's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Merck Price-to-Free-Cash-Flow Distribution
For the Drug Manufacturers industry and Healthcare sector, Merck's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Merck's Price-to-Free-Cash-Flow falls in comparison to its industry or sector. The grey bar indicates the Price-to-Free-Cash-Flow's extreme value range as defined by GuruFocus.
Merck Price-to-Free-Cash-Flow Calculation
Merck's Price-to-Free-Cash-Flow ratio for today is calculated as
Merck's Share Price of today is $105.84.
Merck's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.26.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Merck Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Merck's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
0.5(0.47%) Volume: 6,024,448 11:08PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
MRK has been successfully added to your 
